Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept vs Cyclosporine in Kidney Transplant
NCT00035555Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2001
- Primary completion
- Jan 2004
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in kidney transplant rejection, sponsored by Bristol Myers Squibb. Started Mar 2001; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00035555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035555.